Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regenerative Treatment of Female Genital Atrophy with PRP
NCT07306611Phase 2Completed
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Hydrogel Systems, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Vulvovaginal atrophy (VVA) comparing PRP Group with Placebo Group (2 arms). Primary endpoints: Vaginal Maturation Index at 6 months, Vaginal pH at 6 months and 2 more. Started Jun 2024; status: completed.
02
Drugs
autologous platelet rich gel
03
Conditions
Vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT07306611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07306611.